Systematic review: economic evaluations of HCV screening in the direct-acting antivirals era

Cost-effectiveness of hepatitis C screening and treatment linkage intervention in US methadone maintenance treatment programs

(2018) Bruce R. Schackman et al.   DRUG AND ALCOHOL DEPENDENCE

New virological tools for screening, diagnosis and monitoring of hepatitis B and C in resource-limited settings

(2018) Stéphane Chevaliez et al.   JOURNAL OF HEPATOLOGY

Challenges and perspectives of direct antivirals for the treatment of hepatitis C virus infection

(2018) Johannes Vermehren et al.   JOURNAL OF HEPATOLOGY

Burden of liver disease in Europe: Epidemiology and analysis of risk factors to identify prevention policies

(2018) Laura Pimpin et al.   JOURNAL OF HEPATOLOGY

The removal of DAA restrictions in Europe – one step closer to eliminating HCV as a major public health threat

(2018) Alison D. Marshall et al.   JOURNAL OF HEPATOLOGY

Feasibility of reaching world health organization targets for hepatitis C and the cost-effectiveness of alternative strategies

(2018) T. Wisløff et al.   JOURNAL OF VIRAL HEPATITIS

Effectiveness and cost-effectiveness of interventions targeting harm reduction and chronic hepatitis C cascade of care in people who inject drugs: The case of France

(2018) A. Cousien et al.   JOURNAL OF VIRAL HEPATITIS

Approaches for simplified HCV diagnostic algorithms

(2018) Slim Fourati et al.   Journal of the International AIDS Society

Intervention Packages to Reduce the Impact of HIV and HCV Infections Among People Who Inject Drugs in Eastern Europe and Central Asia: A Modeling and Cost-effectiveness Study

(2018) Guillaume Mabileau et al.   Open Forum Infectious Diseases

Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017

(2018) Spencer L James et al.   LANCET

Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017

(2018) Gregory A Roth et al.   LANCET

Late hepatitis B and C diagnosis in relation to disease decompensation and hepatocellular carcinoma development

(2017) Hasina Samji et al.   JOURNAL OF HEPATOLOGY

In an era of highly effective treatment, hepatitis C screening of the United States general population should be considered

(2017) Zobair Younossi et al.   LIVER INTERNATIONAL

Identifying cost-effective screening algorithms for active hepatitis C virus infections in a high prevalence setting

(2017) Paul Jülicher et al.   JOURNAL OF MEDICAL ECONOMICS

Estimating the Cost-Effectiveness of One-Time Screening and Treatment for Hepatitis C in Korea

(2017) Do Young Kim et al.   PLoS One

Effective but costly: How to tackle difficult trade-offs in evaluating health improving technologies in liver diseases

(2016) Lorenzo Giovanni Mantovani et al.   HEPATOLOGY

Cost-Effectiveness Analysis of Different Testing Strategies that Use Antibody Levels to Detect Chronic Hepatitis C in Blood Donors

(2016) Víctor Granados-García et al.   PLoS One

Cost effectiveness of adding nucleic acid testing to hepatitis B, hepatitis C, and human immunodeficiency virus screening of blood donations in Zimbabwe

(2016) Nyashadzaishe Mafirakureva et al.   TRANSFUSION

Public health impact of comprehensive hepatitis C screening and treatment in the French baby-boomer population

(2016) Olivier Ethgen et al.   JOURNAL OF MEDICAL ECONOMICS

Prevention of Hepatitis C by Screening and Treatment in U.S. Prisons

(2015) Tianhua He et al.   ANNALS OF INTERNAL MEDICINE

Restrictions for Medicaid Reimbursement of Sofosbuvir for the Treatment of Hepatitis C Virus Infection in the United States

(2015) Soumitri Barua et al.   ANNALS OF INTERNAL MEDICINE

Cost-effectiveness of screening for hepatitis C in Canada

(2015) William W.L. Wong et al.   CANADIAN MEDICAL ASSOCIATION JOURNAL

Costs and consequences: Hepatitis C seroprevalence in the military and its impact on potential screening strategies

(2015) David M. Brett-Major et al.   HEPATOLOGY

Cost-effectiveness of strategies for testing current hepatitis C virus infection

(2015) Michael K. Chapko et al.   HEPATOLOGY

Is antenatal screening for hepatitis C virus cost-effective? A decade’s experience at a London centre

(2015) Nowlan Selvapatt et al.   JOURNAL OF HEPATOLOGY

Hepatitis C

(2015) Daniel P Webster et al.   LANCET

Cost-Effectiveness of HBV and HCV Screening Strategies – A Systematic Review of Existing Modelling Techniques

(2015) Claudia Geue et al.   PLoS One

Consolidated Health Economic Evaluation Reporting Standards (CHEERS)—Explanation and Elaboration: A Report of the ISPOR Health Economic Evaluation Publication Guidelines Good Reporting Practices Task Force

(2013) Don Husereau et al.   VALUE IN HEALTH